Skip to main content
Clinical Trials/ACTRN12624000293561
ACTRN12624000293561
Not yet recruiting
未知

A Pilot Feasibility randomised controlled trial of Patient-Reported Outcome Measure Monitoring and Feedback to Improve Disability and Quality of Life in Critically Ill Patients Who Survive Extracorporeal Membrane Oxygenation (ECMO)

Alfred Health0 sites40 target enrollmentMarch 21, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Extracorporeal Membrane Oxygenation (ECMO)
Sponsor
Alfred Health
Enrollment
40
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 21, 2024
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Received ECMO therapy in ICU for \>24 hours;
  • 2\. Adults aged 18 years old or more.
  • 3\. Expected to survive to hospital discharge;
  • 4\. Enrolled in the EXCEL registry.

Exclusion Criteria

  • Documented pre\-existing medical diagnosis of cognitive impairment e.g. dementia;
  • Not expected to reside in Australia for 12 months following randomisation;
  • No regular GP or unable to identify a primary care practice.
  • Patient opts out of EXCEL Registry’s long\-term follow up
  • Hospital length of stay \>5 months post ECMO commencement

Outcomes

Primary Outcomes

Not specified

Similar Trials